RemeGen Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 01:20AM GMT
Unidentified Participant

Please join me in welcoming Dr. Fang Jianmin, Co-Founder, CEO and CSO of RemeGen, for his roadshow presentation on the topic of RemeGen focusing on innovative Biologics for unmet medical need.

Dr. Fang Jianmin - RemeGen Co. Ltd. - Co-Founder, CEO & CSO

My name is Jianmin Fang. I am the Founder, CEO, CSO of RemeGen (foreign language). Remegen is -- just first will give an overview about Remegen. Remegen was founded in 2008. Currently we have over 1,000 employees. We are headquartered in Yantai in China with an R&D facility in Shanghai and also in South San Francisco, California. Also we have a regulatory clinical office in Beijing and Washington DC.

We are dedicated to the discovery, development, manufacturing and the commercialization of innovative biologics to address global medical need for unmet medical need. So our innovation -- we are focused on autoimmune disease, oncologic and ophthalmic disease. And currently we have two innovative biologics, RC18 and RC48, filed the NDA or BLA in China, so ready for commercialization.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot